Standard

European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. / On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee.

In: Pediatric radiology, Vol. 51, No. 10, 09.2021, p. 1940-1951.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee 2021, 'European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology', Pediatric radiology, vol. 51, no. 10, pp. 1940-1951. https://doi.org/10.1007/s00247-021-05081-0

APA

On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee (2021). European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. Pediatric radiology, 51(10), 1940-1951. https://doi.org/10.1007/s00247-021-05081-0

Vancouver

On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. Pediatric radiology. 2021 Sep;51(10):1940-1951. https://doi.org/10.1007/s00247-021-05081-0

Author

On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee. / European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. In: Pediatric radiology. 2021 ; Vol. 51, No. 10. pp. 1940-1951.

BibTeX

@article{e63ad20d0f594443a2103ab107119dc1,
title = "European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology",
abstract = "Appropriate imaging is essential in the treatment of children and adolescents with rhabdomyosarcoma. For adequate stratification and optimal individualised local treatment utilising surgery and radiotherapy, high-quality imaging is crucial. The paediatric radiologist, therefore, is an essential member of the multi-disciplinary team providing clinical care and research. This manuscript presents the European rhabdomyosarcoma imaging guideline, based on the recently developed guideline of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Imaging Committee. This guideline was developed in collaboration between the EpSSG Imaging Committee, the Cooperative Weichteilsarkom Studiengruppe (CWS) Imaging Group, and the Oncology Task Force of the European Society of Paediatric Radiology (ESPR). MRI is recommended, at diagnosis and follow-up, for the evaluation of the primary tumour and its relationship to surrounding tissues, including assessment of neurovascular structures and loco-regional lymphadenopathy. Chest CT along with [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT or PET/MRI are recommended for the detection and evaluation of loco-regional and distant metastatic disease. Guidance on the estimation of treatment response, optimal long-term follow-up, technical imaging settings and standardised reporting are described. This European imaging guideline outlines the recommendations for imaging in children and adolescents with rhabdomyosarcoma, with the aim to harmonise imaging and to advance patient care.",
keywords = "Adolescent, Child, Consensus, Diagnosis, Magnetic resonance imaging, Positron emission tomography/computed tomography, Rhabdomyosarcoma, Sarcoma, Staging",
author = "{van Ewijk}, Roelof and Schoot, {Reineke A.} and Monika Sparber-Sauer and {ter Horst}, {Simone A. J.} and Nina Jehanno and Lise Borgwardt and {de Keizer}, Bart and Merks, {Johannes H. M.} and {de Luca}, Alberto and Kieran McHugh and {von Kalle}, Thekla and Sch{\"a}fer, {J. rgen F.} and {van Rijn}, {Rick R.} and {On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee} and Amine Bouhamama and Ana Coma and {di Paolo}, {Pier Luigi} and Fajardo, {Raquel Davila} and Christiane Franzius and Chiara Giraudo and {de Jonge}, {Gideon M.} and Daniel Levine and David MacVicar and Henry Mandeville and Shruti Moholkar and Carlo Morosi and M{\"u}ller, {Lil-Sophie Ording} and Erika Pace and Rogers, {Timothy N.} and {van Scheltinga}, {Sheila Terwisscha} and Nelleke Tolboom",
note = "Funding Information: We acknowledge Mascha van der Kwaak (MRI technician, Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands) and Sita Ramman (MRI technician, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands) for their support in developing the MRI protocols. Roelof van Ewijk has been supported by the KIKA Foundation (Children Cancer-free, number 357) for this work. Funding Information: We acknowledge Mascha van der Kwaak (MRI technician, Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands) and Sita Ramman (MRI technician, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands) for their support in developing the MRI protocols. Roelof van Ewijk has been supported by the KIKA Foundation (Children Cancer-free, number 357) for this work. Collaborators: Amine Bouhamama, Department of Radiology, Centre L?on B?rard, Comprehensive Cancer Centre, Lyon, France Ana Coma, Department of Radiology, Hospital Vall d?Hebron, Barcelona, Spain Pier Luigi Di Paolo, Department or Radiology, Bambino Ges? Children?s Hospital, Rome, Italy Raquel Davila Fajardo, Department of Radiation Oncology, University Medical Centre Utrecht, and Princess M?xima Centre for Paediatric Oncology, Utrecht, The Netherlands Christiane Franzius, Zentrum f?r Nukleramedizin und PET/CT, Zentrum f?r moderne Diagnostik (ZEMODI), Bremen, Germany Chiara Giraudo, Department of Radiology, Padua, Italy Gideon M. de Jonge, Department of Radiology and Nuclear Medicine, Princess M?xima Centre for Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, The Netherlands Daniel Levine, Department of Nuclear Medicine, Royal Marsden NHS Foundation Trust, London, UK David MacVicar, Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK Henry Mandeville, Department of Radiotherapy, Royal Marsden Hospital, Sutton, UK Shruti Moholkar, Department of Radiology, Birmingham Children?s Hospital, Birmingham, UK Carlo Morosi, Department of Radiology, Istituto Nazionale Tumori, Milan, Italy Lil-Sophie Ording M?ller, Department of Radiology, Oslo University Hospital, Oslo, Norway Erika Pace, Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK Timothy N. Rogers, Department of Paediatric Surgery, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; Roberto Stramare, Department of Radiology, Padua, Italy Sheila Terwisscha van Scheltinga, Department of Paediatric Surgery, Princess M?xima Centre for Paediatric Oncology, Utrecht, The Netherlands Nelleke Tolboom, Department of Radiology and Nuclear Medicine, Princess M?xima Centre for Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, The Netherlands Publisher Copyright: {\textcopyright} 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = sep,
doi = "10.1007/s00247-021-05081-0",
language = "English",
volume = "51",
pages = "1940--1951",
journal = "Pediatric radiology",
issn = "0301-0449",
publisher = "Springer Verlag",
number = "10",

}

RIS

TY - JOUR

T1 - European guideline for imaging in paediatric and adolescent rhabdomyosarcoma — joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology

AU - van Ewijk, Roelof

AU - Schoot, Reineke A.

AU - Sparber-Sauer, Monika

AU - ter Horst, Simone A. J.

AU - Jehanno, Nina

AU - Borgwardt, Lise

AU - de Keizer, Bart

AU - Merks, Johannes H. M.

AU - de Luca, Alberto

AU - McHugh, Kieran

AU - von Kalle, Thekla

AU - Schäfer, J. rgen F.

AU - van Rijn, Rick R.

AU - On behalf of the Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee

AU - Bouhamama, Amine

AU - Coma, Ana

AU - di Paolo, Pier Luigi

AU - Fajardo, Raquel Davila

AU - Franzius, Christiane

AU - Giraudo, Chiara

AU - de Jonge, Gideon M.

AU - Levine, Daniel

AU - MacVicar, David

AU - Mandeville, Henry

AU - Moholkar, Shruti

AU - Morosi, Carlo

AU - Müller, Lil-Sophie Ording

AU - Pace, Erika

AU - Rogers, Timothy N.

AU - van Scheltinga, Sheila Terwisscha

AU - Tolboom, Nelleke

N1 - Funding Information: We acknowledge Mascha van der Kwaak (MRI technician, Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands) and Sita Ramman (MRI technician, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands) for their support in developing the MRI protocols. Roelof van Ewijk has been supported by the KIKA Foundation (Children Cancer-free, number 357) for this work. Funding Information: We acknowledge Mascha van der Kwaak (MRI technician, Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands) and Sita Ramman (MRI technician, Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands) for their support in developing the MRI protocols. Roelof van Ewijk has been supported by the KIKA Foundation (Children Cancer-free, number 357) for this work. Collaborators: Amine Bouhamama, Department of Radiology, Centre L?on B?rard, Comprehensive Cancer Centre, Lyon, France Ana Coma, Department of Radiology, Hospital Vall d?Hebron, Barcelona, Spain Pier Luigi Di Paolo, Department or Radiology, Bambino Ges? Children?s Hospital, Rome, Italy Raquel Davila Fajardo, Department of Radiation Oncology, University Medical Centre Utrecht, and Princess M?xima Centre for Paediatric Oncology, Utrecht, The Netherlands Christiane Franzius, Zentrum f?r Nukleramedizin und PET/CT, Zentrum f?r moderne Diagnostik (ZEMODI), Bremen, Germany Chiara Giraudo, Department of Radiology, Padua, Italy Gideon M. de Jonge, Department of Radiology and Nuclear Medicine, Princess M?xima Centre for Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, The Netherlands Daniel Levine, Department of Nuclear Medicine, Royal Marsden NHS Foundation Trust, London, UK David MacVicar, Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK Henry Mandeville, Department of Radiotherapy, Royal Marsden Hospital, Sutton, UK Shruti Moholkar, Department of Radiology, Birmingham Children?s Hospital, Birmingham, UK Carlo Morosi, Department of Radiology, Istituto Nazionale Tumori, Milan, Italy Lil-Sophie Ording M?ller, Department of Radiology, Oslo University Hospital, Oslo, Norway Erika Pace, Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK Timothy N. Rogers, Department of Paediatric Surgery, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom; Roberto Stramare, Department of Radiology, Padua, Italy Sheila Terwisscha van Scheltinga, Department of Paediatric Surgery, Princess M?xima Centre for Paediatric Oncology, Utrecht, The Netherlands Nelleke Tolboom, Department of Radiology and Nuclear Medicine, Princess M?xima Centre for Paediatric Oncology, Wilhelmina Children's Hospital/University Medical Centre Utrecht, Utrecht, The Netherlands Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/9

Y1 - 2021/9

N2 - Appropriate imaging is essential in the treatment of children and adolescents with rhabdomyosarcoma. For adequate stratification and optimal individualised local treatment utilising surgery and radiotherapy, high-quality imaging is crucial. The paediatric radiologist, therefore, is an essential member of the multi-disciplinary team providing clinical care and research. This manuscript presents the European rhabdomyosarcoma imaging guideline, based on the recently developed guideline of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Imaging Committee. This guideline was developed in collaboration between the EpSSG Imaging Committee, the Cooperative Weichteilsarkom Studiengruppe (CWS) Imaging Group, and the Oncology Task Force of the European Society of Paediatric Radiology (ESPR). MRI is recommended, at diagnosis and follow-up, for the evaluation of the primary tumour and its relationship to surrounding tissues, including assessment of neurovascular structures and loco-regional lymphadenopathy. Chest CT along with [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT or PET/MRI are recommended for the detection and evaluation of loco-regional and distant metastatic disease. Guidance on the estimation of treatment response, optimal long-term follow-up, technical imaging settings and standardised reporting are described. This European imaging guideline outlines the recommendations for imaging in children and adolescents with rhabdomyosarcoma, with the aim to harmonise imaging and to advance patient care.

AB - Appropriate imaging is essential in the treatment of children and adolescents with rhabdomyosarcoma. For adequate stratification and optimal individualised local treatment utilising surgery and radiotherapy, high-quality imaging is crucial. The paediatric radiologist, therefore, is an essential member of the multi-disciplinary team providing clinical care and research. This manuscript presents the European rhabdomyosarcoma imaging guideline, based on the recently developed guideline of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Imaging Committee. This guideline was developed in collaboration between the EpSSG Imaging Committee, the Cooperative Weichteilsarkom Studiengruppe (CWS) Imaging Group, and the Oncology Task Force of the European Society of Paediatric Radiology (ESPR). MRI is recommended, at diagnosis and follow-up, for the evaluation of the primary tumour and its relationship to surrounding tissues, including assessment of neurovascular structures and loco-regional lymphadenopathy. Chest CT along with [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT or PET/MRI are recommended for the detection and evaluation of loco-regional and distant metastatic disease. Guidance on the estimation of treatment response, optimal long-term follow-up, technical imaging settings and standardised reporting are described. This European imaging guideline outlines the recommendations for imaging in children and adolescents with rhabdomyosarcoma, with the aim to harmonise imaging and to advance patient care.

KW - Adolescent

KW - Child

KW - Consensus

KW - Diagnosis

KW - Magnetic resonance imaging

KW - Positron emission tomography/computed tomography

KW - Rhabdomyosarcoma

KW - Sarcoma

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=85108231910&partnerID=8YFLogxK

U2 - 10.1007/s00247-021-05081-0

DO - 10.1007/s00247-021-05081-0

M3 - Article

C2 - 34137936

VL - 51

SP - 1940

EP - 1951

JO - Pediatric radiology

JF - Pediatric radiology

SN - 0301-0449

IS - 10

ER -

ID: 18761213